{"contentid": 488263, "importid": NaN, "name": "Sterling Pharma Solutions confirms acquisition of ADC Bio", "introduction": "Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, says it has acquired fellow UK-based ADC Biotechnology, a bioconjugation development services business specializing in antibody drug conjugates (ADCs).", "content": "<p>Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, says it has acquired fellow UK-based ADC Biotechnology, a bioconjugation development services business specializing in antibody drug conjugates (ADCs).</p>\n<p>This follows an announcement by Sterling in December of a strategic investment into the ADC Bio business, with a view to acquisition in 2021. Financial terms of the transaction were not revealed.</p>\n<p>The North Wales facility will rebrand to become part of the Sterling Pharma Solutions international network. Together the teams will establish a center of excellence for bioconjugation and ADC development and manufacturing services, which combine Sterling&rsquo;s 50 years of experience in cGMP manufacturing, quality processes and compliance, with the expertise of the ADC Bio team and the state-of-the-art facilities available at Deeside.</p>\n<p>A multi-million pound investment will support the growth of the company&rsquo;s ADC capabilities, which will include growing and developing the existing bioconjugation technical services team and expanding the analytical services team particularly in the cGMP area. As well as this, the team will develop and establish cGMP bioconjugation/ADC manufacturing at Deeside in 2022.</p>\n<p>This announcement follows Sterling&rsquo;s acquisition of a second US API development and manufacturing facility in Wisconsin, USA, in September last year. The UK headquartered CDMO now employs over 750 people across the UK and the US.</p>\n<p>&nbsp;</p>", "date": "2021-04-06 16:07:00", "meta_title": "Sterling Pharma Solutions confirms acquisition of ADC Bio", "meta_keywords": "Sterling Pharma Solutions, ADC Biotechnology, Acquisition, M&A, ADCs", "meta_description": "Sterling Pharma Solutions confirms acquisition of ADC Bio", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-06 16:05:58", "updated": "2021-04-06 16:14:40", "access": NaN, "url": "https://www.thepharmaletter.com/article/sterling-pharma-solutions-confirms-acquisition-of-adc-bio", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "adc_biotechnology_large.jpg", "image2id": "adc_biotechnology_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": "Contract manufacturing organization", "sector_tag": "Biotechnology", "therapy area_tag": "Oncology", "topic_tag": "Companies, mergers and acquisitions, Management, Outsourcing, CRO and CMO", "geography_tag": "UK", "company_tag": "ADC Biotechnology, Sterling Pharma Solutions", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-06 16:07:00"}